Status: Recruiting
Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis
A Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of Nebulised RESP30TB in Adults with Newly Diagnosed, Rifampicin Susceptible Pulmonary Tuberculosis
Participants needed: 24
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Thirty Respiratory LimitedUpdated: Jan 12, 2026Locations: 1
Eligibility criteria
Provide written, informed consent prior to all trial-related procedures and agre... [+6]
HIV positive AND CD4 < 350 cells/mm3 OR are receiving antiviral therapy (ART) [+7]